Sanofi-Aventis continued to diversify into consumer healthcare and the emerging markets in the 2010 first quarter, while also strengthening its franchise in diabetes with the signing of partnerships in glucose monitoring and diabetes research.
The French multinational gave an update on its new strategic direction with the release of its 2010 first quarter results on 29 April.